Keywords
Last Name
Institution

Barry Uretsky

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Med, College of Medicine
DivisionInternal Med Cardiology
Address3S 04 Shorey
324 UAMS Campus Dr.
Mail Slot # 532
Little Rock AR 72205
Phone501-686-7882
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hakeem A, Uretsky BF. Clinical and Prognostic Value of Post-Stenting FFR. JACC Cardiovasc Interv. 2017 Aug 14; 10(15):1596. PMID: 28797435.
      View in: PubMed
    2. Hakeem A, Almomani A, Uretsky BF. Role of fractional flow reserve in the evaluation and management of patients with acute coronary syndrome. Curr Opin Cardiol. 2017 Aug 10. PMID: 28799978.
      View in: PubMed
    3. Pothineni NV, Edupuganti MM, Almomani A, Payne J, Raina S, Fnu S, Abualsuod A, Wong J, Uretsky BF, Hakeem A. Comparison of the Prognostic Value of Non-ischemic Fractional flow reserve using Intracoronary versus Intravenous Adenosine. EuroIntervention. 2017 Jun 13. PMID: 28606887.
      View in: PubMed
    4. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Doing A, Toma C, Uretsky B, Choi J, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Martinez-Parachini JR, Karatasakis A, Danek BA, Alame AJ, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. J Invasive Cardiol. 2017 Aug; 29(8):264-270. PMID: 28570257.
      View in: PubMed
    5. Azzalini L, Carlino M, Brilakis ES, Vo M, Rinfret S, Uretsky BF, Karmpaliotis D, Colombo A. Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture". Catheter Cardiovasc Interv. 2017 Mar 17. PMID: 28303648.
      View in: PubMed
    6. Vallurupalli S, Uretsky BF. Letter by Vallurupalli and Uretsky Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting)". Circulation. 2017 Feb 28; 135(9):e140-e141. PMID: 28242644.
      View in: PubMed
    7. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):225-232. PMID: 28805036.
      View in: PubMed
    8. Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NVK, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF. A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation deployment method. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):233-240. PMID: 28112479.
      View in: PubMed
    9. Karatasakis A, Iwnetu R, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Kandzari DE, Lembo NJ, Patel M, Mahmud E, Lombardi WL, Wyman RM, Grantham JA, Doing AH, Toma C, Choi JW, Uretsky BF, Moses JW, Kirtane AJ, Ali ZA, Parikh M, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2017 Apr; 29(4):116-122. PMID: 28089997.
      View in: PubMed
    10. Agarwal SK, Kasula S, Almomani A, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization. Am Heart J. 2017 Feb; 184:10-16. PMID: 27892882.
      View in: PubMed
    11. Hakeem A, Edupuganti MM, Almomani A, Pothineni NV, Payne J, Abualsuod AM, Bhatti S, Ahmed Z, Uretsky BF. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve. J Am Coll Cardiol. 2016 Sep 13; 68(11):1181-1191. PMID: 27609680.
      View in: PubMed
    12. Kasula S, Agarwal SK, Hacioglu Y, Pothineni NK, Bhatti S, Ahmed Z, Uretsky B, Hakeem A. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes. Heart. 2016 Dec 15; 102(24):1988-1994. PMID: 27492942.
      View in: PubMed
    13. Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016 May 23; 9(10):1022-31. PMID: 27198682.
      View in: PubMed
    14. Vallurupalli S, Uretsky BF. Deploying bioresorbable vascular scaffolds--tardus, altius, amplius!! Catheter Cardiovasc Interv. 2016 Apr; 87(5):847-8. PMID: 27085025.
      View in: PubMed
    15. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions. J Invasive Cardiol. 2016 Mar; 28(3):94-7. PMID: 26945250.
      View in: PubMed
    16. Bhatheja S, Panchal HB, Barry N, Mukherjee D, Uretsky BF, Paul T. Valvular performance and aortic regurgitation following transcatheter aortic valve replacement using Edwards valve versus CoreValve for severe aortic stenosis: A Meta-analysis. Cardiovasc Revasc Med. 2016 Jun; 17(4):248-55. PMID: 26948087.
      View in: PubMed
    17. Pothineni NV, Shah NS, Rochlani Y, Nairooz R, Raina S, Leesar MA, Uretsky BF, Hakeem A. U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016 Feb 16; 67(6):732-3. PMID: 26868697.
      View in: PubMed
    18. Hakeem A, Garg A, Bhatti S, Ahmed Z, Uretsky BF. Fractional flow reserve in acute coronary syndrome: a word of caution. EuroIntervention. 2015 Dec; 11(8):e1-2. PMID: 26696318.
      View in: PubMed
    19. Carlino M, Ruparelia N, Thomas G, Brooks M, Uretsky BF, Brilakis ES, Karmpaliotis D, Hanratty C, Walsh S, Spratt J, Colombo A. Modified contrast microinjection technique to facilitate chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2016 May; 87(6):1036-41. PMID: 26356491.
      View in: PubMed
    20. Carlino M, Figini F, Ruparelia N, Uretsky BF, Godino C, Latib A, Bertoldi L, Brilakis E, Karmpaliotis D, Antoniucci D, Margonato A, Colombo A. Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade. Catheter Cardiovasc Interv. 2016 Apr; 87(5):884-92. PMID: 26308750.
      View in: PubMed
    21. Pothineni NV, Bahia A, Gobal F, Ahmed Z, Uretsky BF, Hakeem A. "DVT" of the Heart: A "Novel" Treatment for an Old Problem. JACC Cardiovasc Interv. 2015 Aug 24; 8(10):e165-6. PMID: 26315751.
      View in: PubMed
    22. Vallurupalli S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, Hakeem A, Uretsky BF. Optimization of stent implantation using a high pressure inflation protocol. Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):65-72. PMID: 26152685.
      View in: PubMed
    23. Vallurupalli S, Uretsky BF. Physician, Shield Thyself! J Invasive Cardiol. 2015 Jul; 27(7):317. PMID: 26136278.
      View in: PubMed
    24. Uretsky BF, Mathew J, Ahmed Z, Hakeem A. Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm. Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):90-100. PMID: 26119718.
      View in: PubMed
    25. Hakeem A, Uretsky BF. "Just do it!" redux. Catheter Cardiovasc Interv. 2015 May; 85(6):977-8. PMID: 25904224.
      View in: PubMed
    26. Assad-Kottner C, Hakeem A, Uretsky BF. Modified dual guide catheter ("ping-pong") technique to treat left internal mammary artery graft perforation. Catheter Cardiovasc Interv. 2015 Jul; 86(1):E28-31. PMID: 25044448.
      View in: PubMed
    27. Agarwal SK, Vallurupalli S, Uretsky BF, Hakeem A. Effectiveness of colchicine for the prevention of recurrent pericarditis and post-pericardiotomy syndrome: an updated meta-analysis of randomized clinical data. Eur Heart J Cardiovasc Pharmacother. 2015 Apr; 1(2):117-25. PMID: 27533981.
      View in: PubMed
    28. Uretsky BF, Carlino M. How to improve your "STAR quality". Catheter Cardiovasc Interv. 2015 Feb 15; 85(3):391-2. PMID: 25684717.
      View in: PubMed
    29. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015 Feb; 22(1):162-215. PMID: 25523415.
      View in: PubMed
    30. Carlino M, Magri CJ, Uretsky BF, Brilakis ES, Walsh S, Spratt JC, Hanratty C, Grantham JA, Rinfret S, Thompson CA, Lombardi WL, Galassi AR, Sianos G, Latib A, Garbo R, Karmpaliotis D, Kandzari DE, Colombo A. Treatment of the chronic total occlusion: a call to action for the interventional community. Catheter Cardiovasc Interv. 2015 Apr; 85(5):771-8. PMID: 25382239.
      View in: PubMed
    31. Zhu H, Cao M, Figueroa JA, Cobos E, Uretsky BF, Chiriva-Internati M, Hermonat PL. AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet. J Transl Med. 2014 Sep 20; 12:252. PMID: 25236373; PMCID: PMC4189750.
    32. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):2215-45. PMID: 25085962.
      View in: PubMed
    33. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):e278-333. PMID: 25085961.
      View in: PubMed
    34. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014 Dec 09; 64(22):e77-137. PMID: 25091544.
      View in: PubMed
    35. Mallikarjuna Rao Edupuganti M, Marmagkiolis K, Cilingiroglu M, Uretsky BF, Hakeem A. Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation. Cardiovasc Revasc Med. 2014 Nov-Dec; 15(8):414-20. PMID: 25204491.
      View in: PubMed
    36. Brilakis ES, Karmpaliotis D, Werner GS, Spratt JC, Uretsky BF, Luna M, Banerjee S. Developments in coronary chronic total occlusion percutaneous coronary interventions: 2014 state-of-the-art update. J Invasive Cardiol. 2014 Jun; 26(6):261-6. PMID: 24907082.
      View in: PubMed
    37. Hakeem A, Uretsky B. Regadenoson for FFR: time to say good-bye to adenosine? Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):375-6. PMID: 24497454.
      View in: PubMed
    38. Assad-Kottner C, Hakeem A, Fontenot E, Uretsky BF. "Tele-mentoring": an interventional procedure using a wearable computer: first-in-man. J Am Coll Cardiol. 2014 Mar 18; 63(10):1022. PMID: 24412453.
      View in: PubMed
    39. Kern MJ, Applegate RJ, Bell M, Brilakis ES, Butman SM, Bach RG, Kaul P, Klein LW, Krucoff MW, Moore JA, Price MJ, Rao SV, Stone GW, Uretsky BF. Conversations in cardiology: bridging antiplatelet therapy before surgery. Catheter Cardiovasc Interv. 2014 Apr 01; 83(5):748-52. PMID: 24395180.
      View in: PubMed
    40. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Rebuttal: change in donor artery fractional flow reserve after recanalization of a chronic total occlusion-not as impressive as some might have us believe. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1187-9. PMID: 24259449.
      View in: PubMed
    41. Garg N, Hakeem A, Gobal F, Uretsky BF. Outcomes of percutaneous coronary intervention of chronic total saphenous vein graft occlusions in the contemporary era. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1025-32. PMID: 24030975.
      View in: PubMed
    42. Hakeem A, Marmagkiolis K, Hacioglu Y, Uretsky BF, Gundogdu B, Leesar M, Bailey SR, Cilingiroglu M. Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2013 Nov-Dec; 14(6):349-55. PMID: 24080379.
      View in: PubMed
    43. Hakeem A, Garg N, Bhatti S, Rajpurohit N, Ahmed Z, Uretsky BF. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data. J Am Heart Assoc. 2013 Aug 07; 2(4):e000354. PMID: 23926119; PMCID: PMC3828792.
    44. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Rebuttal: response to letter by Fan and colleagues regarding "impact on fractional flow reserve of donor artery by chronic total obstruction revascularization". Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1197. PMID: 23813571.
      View in: PubMed
    45. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Reversal of ischemia of donor artery myocardium after recanalization of a chronic total occlusion. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E453-8. PMID: 23703834.
      View in: PubMed
    46. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014 Jan 01; 83(1):9-16. PMID: 23703867.
      View in: PubMed
    47. Uretsky BF. Pathophysiology and prognosis: the curious case of the periprocedural myocardial infarction. Catheter Cardiovasc Interv. 2013 May; 81(6):968-9. PMID: 23606491.
      View in: PubMed
    48. Kern M, Applegate R, Bach RG, Bailey SR, Bashore TM, Bass TA, Bell M, de Bruyne B, Garratt KN, Jeremias A, Kereiakes DJ, Klein LW, Krucoff MW, Mintz GS, Morrison D, Ohman EM, Pichard A, Rosenfield K, Samady H, Stone GW, Tommaso C, Turi ZG, Uretsky B, Vetrovec G, Weiner BH, Welt F, Yeung AC. Conversation in cardiology: should FFR and IVUS be counted as PCI? Catheter Cardiovasc Interv. 2013 Jul 01; 82(1):110-5. PMID: 23404738.
      View in: PubMed
    49. Aggarwal C, Varghese J, Uretsky BF. Left atrial inflow and outflow obstruction as a complication of retrograde approach for chronic total occlusion: report of a case and literature review of left atrial hematoma after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):770-5. PMID: 23239608.
      View in: PubMed
    50. Singla S, Sachdeva R, Uretsky BF. Reply. J Am Coll Cardiol. 2013; 61(10):1123 - .
    51. Cook JR, Mhatre A, Wang FW, Uretsky BF. Prolonged high-pressure is required for optimal stent deployment as assessed by optical coherence tomography. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):521-7. PMID: 23436559.
      View in: PubMed
    52. Singla S, Sachdeva R, Uretsky BF. Reply: To PMID 23083781. J Am Coll Cardiol. 2013 Mar 12; 61(10):1123. PMID: 23333142.
      View in: PubMed
    53. Uretsky BF, Marashdeh M. Percutaneous coronary interventions of chronic total occlusions. Int Cardiac Cathet Handbook. 2013; 201-211.
    54. Kern M, Applegate R, Bach RG, Bailey SR, Bashore TM, Bass TA, Bell M, De Bruyne B, Garratt KN, Jeremias A, Kereiakes DJ, Klein LW, Krucoff MW, Mintz GS, Morrison D, Ohman EM, Prichard A, Rosenfeld K, Samady H, Stone GW, Tommaso C, Turi ZG, Uretsky B, Vetrovec G, Weiner BH, Welt F, Yeung A. Conversations in cardiology: Should FFR and IVUS be counted as PCI?. Cath Cardiovasc Inter. 2013.
    55. Gobal F, Hakeem A, Ahmed Z, Uretsky BF. The critical importance of early intervention in ST-segment elevation myocardial infarction. 2013.
    56. Siddiqi N, Suh WH, Uretsky BF, Edis A, Marashdeh M, Zynda TK, Kern MJ. Difficult subsets for percutaneous coronary interventions: calcific vessels, coronary bypass conduits, elderly patients and cardiac transplantation. 194-200. 2013.
    57. Aleti S, Uretsky BF, Sachdeva R. Utility of fractional flow reserve to determine treatment after recent large myocardial infaction with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2012; 80(5):830-834.
    58. Cook J, Uretsky BF, Sachdeva R. Intervention in the occluded vein graft: with high risk can come great reward: review of techniques with case examples. J Invasive Cardiol. 2012 Nov; 24(11):612-7. PMID: 23117319.
      View in: PubMed
    59. Singla S, Sachdeva R, Uretsky BF. The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. J Am Coll Cardiol. 2012 Nov 13; 60(20):2005-16. PMID: 23083781.
      View in: PubMed
    60. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98. PMID: 22958960.
      View in: PubMed
    61. Singla S, Sachdeva R, Uretsky BF. Normal fractional flow reserve with a critical stenosis supplying viable myocardium. Exp Clin Cardiol. 2012 Sep; 17(3):142-3. PMID: 23620704; PMCID: PMC3628429.
    62. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct; 33(20):2551-67. PMID: 22922414.
      View in: PubMed
    63. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Circulation. 2012 Oct 16; 126(16):2020-35. PMID: 22923432.
      View in: PubMed
    64. Deshmukh AJ, Pant S, Cook J, Sachdeva R, Rutlen D, Uretsky BF. Prasugrel-induced rash. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1123-5. PMID: 22811344.
      View in: PubMed
    65. Mhatre A, Uretsky BF, Sachdeva R. Substrate for complications. J Invasive Cardiol. 2012 Jul; 24(7):E153-6. PMID: 22781487.
      View in: PubMed
    66. Flynn SE, Sachdeva R, Uretsky BF. Symptomatic right ventricular ischemia secondary to a critical stenosis in a nondominant right coronary artery. Catheter Cardiovasc Interv. 2013 Jan 01; 81(1):68-72. PMID: 22422544.
      View in: PubMed
    67. Singla S, Uretsky BF, Sachdeva R. Retrograde fractional flow reserve and recanalization of a chronic total occlusion of a saphenous venous graft. Catheter Cardiovasc Interv. 2012 Dec 01; 80(7):1210-5. PMID: 22121036.
      View in: PubMed
    68. Aleti S, Uretsky BF, Sachdeva R. Utility of fractional flow reserve to determine treatment after recent large myocardial infarction with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):830-4. PMID: 21954209.
      View in: PubMed
    69. Uretsky BF. Does mini-STAR equal mega-success? Catheter Cardiovasc Interv. 2012 Jan 01; 79(1):41-2. PMID: 22190203.
      View in: PubMed
    70. Prayaga S, Uretsky BF, Sachdeva R. ST-elevation myocardial infarction as a complication of retrograde chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2012 Oct 01; 80(4):611-5. PMID: 21805592.
      View in: PubMed
    71. Kalaga R, Uretsky BF, Sachdeva R. Atresia of the left internal mammary artery graft following percutaneous intervention of the left main1. 2011; 23(12):E284 - E287.
    72. Kalaga R, Uretsky BF, Sachdeva R. Atresia of the left internal mammary artery graft following percutaneous intervention of the left main. J Invasive Cardiol. 2011 Dec; 23(12):E284-7. PMID: 22147410.
      View in: PubMed
    73. Uretsky BF. The value of recanalizing a chronic total occlusion. Catheter Cardiovasc Interv. 2011 Sep 01; 78(3):354-5. PMID: 21976426.
      View in: PubMed
    74. Uretsky BF. The value of recanalizing a chronic total occlusion2. 2011; 78(3):354 - 355.
    75. Gobal F, Sachdeva R, Uretsky BF. Computed tomography and angiography of left ventricular diverticulum. J Am Coll Cardiol. 2011 Aug 23; 58(9):e17. PMID: 21851874.
      View in: PubMed
    76. Gobal F, Sachdeva R, Uretsky BF. Computed tomography and angiography of left ventricular diverticulum3. 2011; 58(9):e17 - .
    77. Willis N, Sachdeva R, Uretsky BF. Bare-metal stent thrombosis after noncardiac surgery greater than 10 years after stent implantation11. 2011; 78(2):234 - 236.
    78. Sachdeva R, Uretsky BF, Mehta JL. Determining the significance of side branch lesion during bifurcation stenting. Am J Cardiol. 2011 Jun 15; 107(12):1794-5. PMID: 21640218.
      View in: PubMed
    79. Uretsky BF. Should serum troponin after PCI be used to predict long-term outcomes?.......Not quite yet!7. 2011; 77(7):1031 - 1032.
    80. Sachdeva R, Uretsky BF, Mehta JL. Determining the significance of side branch lesion during bifurcation stenting5. Am J Cardiol. 2011; 107(12):1794 - 1795.
    81. Uretsky BF. Should serum troponin after PCI be used to predict long-term outcomes?.......Not quite yet! Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):1031-2. PMID: 21598354.
      View in: PubMed
    82. Huang MH, Wu Y, Nguyen V, Rastogi S, McConnell BK, Wijaya C, Uretsky BF, Poh KK, Tan HC, Fujise K. Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. Cardiovasc Drugs Ther. 2011 Jun; 25(3):223-32. PMID: 21562974; PMCID: PMC3110274.
    83. Wang FW, Esterbrooks D, Kuo YF, Mooss A, Mohiuddin SM, Uretsky BF. Outcomes after carotid artery stenting and endarterectomy in the Medicare population. Stroke. 2011 Jul; 42(7):2019-25. PMID: 21617150.
      View in: PubMed
    84. Klein LW, Ho KK, Singh M, Anderson HV, Hillegass WB, Uretsky BF, Chambers C, Rao SV, Reilly J, Weiner BH, Kern M, Bailey S. Quality assessment and improvement in interventional cardiology: a Position Statement of the Society of Cardiovascular Angiography and Interventions, Part II: public reporting and risk adjustment. Catheter Cardiovasc Interv. 2011 Oct 01; 78(4):493-502. PMID: 21547998.
      View in: PubMed
    85. Uretsky BF. Letter by Uretsky regarding article, "Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial". Circulation. 2011 Apr 05; 123(13):e398; author reply e399. PMID: 21464057.
      View in: PubMed
    86. Willis N, Sachdeva R, Uretsky BF. Bare-metal stent thrombosis after noncardiac surgery greater than 10 years after stent implantation. Catheter Cardiovasc Interv. 2011 Aug 01; 78(2):234-6. PMID: 21413118.
      View in: PubMed
    87. Klein LW, Uretsky BF, Chambers C, Anderson HV, Hillegass WB, Singh M, Ho KK, Rao SV, Reilly J, Weiner BH, Kern M, Bailey S. Quality assessment and improvement in interventional cardiology: a position statement of the Society of Cardiovascular Angiography and Interventions, part 1: standards for quality assessment and improvement in interventional cardiology. Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):927-35. PMID: 21370384.
      View in: PubMed
    88. Rochon B, Chami Y, Sachdeva R, Bissett JK, Willis N, Uretsky BF. Manual aspiration thrombectomy in acute ST elevation myocardial infarction: New gold standard. World J Cardiol. 2011 Feb 26; 3(2):43-7. PMID: 21390195; PMCID: PMC3051147.
    89. Sachdeva R, Uretsky BF. The effect of CTO recanalization on FFR of the donor artery. Catheter Cardiovasc Interv. 2011 Feb 15; 77(3):367-9. PMID: 20853349.
      View in: PubMed
    90. Sachdeva R, Uretsky BF. The effect of CTO recanalization on FFR of the donor artery15. 2011; 77(3):367 - 369.
    91. Rochon B, Chami Y, Sachdeva R, Bissett JK, Willis N, Uretsky BF. Manual aspiration thrombectomy in acute ST elevation myocardial infarction: New gold standard12. World J Cardiol. 2011; 3(2):43 - 47.
    92. Aleti S, Bansal D, Agrawal M, Uretsky BF, Sachdeva R. Effect of chronic angiotensin converting enzyme inhibitor therapy on myocardial injury in patients undergoing percutaneous coronary interventions. J Invasive Cardiol. 2011 Feb; 23(2):72-5. PMID: 21297204.
      View in: PubMed
    93. Sudhakar S, Sewani A, Agrawal M, Uretsky BF. Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (MAIVF): A comprehensive review2. J Am Soc Echocardiogr. 2010; 23(10):1009 - 1018.
    94. Sudhakar S, Sewani A, Agrawal M, Uretsky BF. Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (MAIVF): A comprehensive review. J Am Soc Echocardiogr. 2010 Oct; 23(10):1009-18; quiz 1112. PMID: 20868952.
      View in: PubMed
    95. Uretsky BF. Primary PCI for the "late presenter" with STEMI: how late is too late? Catheter Cardiovasc Interv. 2010 Oct 01; 76(4):471-2. PMID: 20882646.
      View in: PubMed
    96. Uretsky BF. IIb or not IIb? Toward a rational application of left main stenting. J Am Coll Cardiol. 2010 Jun 08; 55(23):2553-5. PMID: 20513594.
      View in: PubMed
    97. Uretsky BF. IIb or not IIb? Toward a rational application of left main stenting3. 2010; 55(23):2553 - 2555.
    98. Huang MH, Lui CY, Abusaid GH, Poh KK, Barbagelata AN, Uretsky BF, Fujise K. Cardiac calcitonin gene-related peptide and left ventricular hypertrophy in the cardiac allograft6. J Heart Lung Transplant. 2010; 29(4):487 - 488.
    99. Sachdeva R, Hughes B, Uretsky BF. Retrograde approach to a totally occluded right coronary artery via a septal perforator artery: the tale of a long and winding wire. J Invasive Cardiol. 2010 Apr; 22(4):E65-6. PMID: 20351398.
      View in: PubMed
    100. Agarwal M, Uretsky B, Sachdeva R. ST-segment elevation myocardial infarction in severe coronary artery stenosis: a case series. J Invasive Cardiol. 2010 Mar; 22(3):E34-6. PMID: 20197586.
      View in: PubMed
    101. Uretsky BF. Time for left main stenting in patients with LV dysfunction? Proceed with caution! Catheter Cardiovasc Interv. 2010 Mar 01; 75(4):594-5. PMID: 20333658.
      View in: PubMed
    102. Huang MH, Lui CY, Abusaid GH, Poh KK, Barbagelata AN, Uretsky BF, Fujise K. Cardiac calcitonin gene-related peptide and left ventricular hypertrophy in the cardiac allograft. J Heart Lung Transplant. 2010 Apr; 29(4):487-8. PMID: 20022769.
      View in: PubMed
    103. Klein LW, Sheldon MW, Brinker J, Mixon TA, Skelding K, Strunk AO, Tommaso CL, Weiner B, Bailey SR, Uretsky B, Kern M, Laskey W. The use of radiographic contrast media during PCI: a focused review: a position statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2009 Nov 01; 74(5):728-46. PMID: 19830793.
      View in: PubMed
    104. Sachdeva R, Uretsky BF. Retrograde recanalization of a chronic total occlusion of a saphenous vein graft. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):575-8. PMID: 19496115.
      View in: PubMed
    105. Uretsky BF. "Drip-and-ship," "Stay-and-pray," "Freight-and-wait (and possibly inflate)" or simply opening the window wider?: Decision-making regarding time delays in the treatment of ST elevation MI. Catheter Cardiovasc Interv. 2009 Sep 01; 74(3):406-7. PMID: 19681117.
      View in: PubMed
    106. Huang MH, Nguyen V, Wu Y, Rastogi S, Lui CY, Birnbaum Y, Wang HQ, Ware DL, Chauhan M, Garg N, Poh KK, Ye L, Omar AR, Tan HC, Uretsky BF, Fujise K. Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovasc Res. 2009 Dec 01; 84(3):452-60. PMID: 19581316.
      View in: PubMed
    107. Uretsky BF. Optimizing bifurcation stenting: the SPRINT technique. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):344-5. PMID: 19213089.
      View in: PubMed
    108. URETSKY. "Drip and ship", "stay and pray", "freight, wait, and possible inflate" or simply open the window wider?. Catheter Cardiovasc Intervent. 2009.
    109. Uretsky BF, Sachdeva R. ST-segment elevation myocardial infarction in severe coronary artery stenosis. J Inv Cardiol. 2009.
    110. Huang MH, Nguyen V, Rastogi S, Wu Y, Lui C, Ware DL, Chauhan MLS, Garg N, Fujise K, Kian KP, Tan HC, Ye L, Razak A, Birnbaum Y, Uretsky BF. Reducing ischemia/reperfusion injury through d-opiod-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signaling. Cardiovascular Research. 2009.
    111. Klein, LW, Sheldon, MW, Brinker, J, Mixon TA, Skelding K, Strunk AO, Tommaso C, Weiner B, Bailey SR, Kern M, Uretsky BF. The use of radiographic contrast media during percutaneous coronary intervention: a focused review. Catheter Cardiovasc Intervention. 2009; 74:728-746.
    112. Uretsky BF. Treating the left main bifurcation lesion: the "three stent solution". Catheter Cardiovasc Interv. 2009 Jan 01; 73(1):42-3. PMID: 19089935.
      View in: PubMed
    113. Uretsky BF. Can I be a star (or at least perform one)? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):797-8. PMID: 19009626.
      View in: PubMed
    114. Uretsky BF, Birnbaum Y, Osman A, Gupta R, Paniagua O, Chamoun A, Pohwani A, Lui C, Lev E, McGehee T, Kumar D, Akhtar A, Anzuini A, Schwarz ER, Wang FW. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv. 2008 Oct 01; 72(4):488-97. PMID: 18814223.
      View in: PubMed
    115. Bansal D, Uretsky BF. Treatment of chronic total occlusion by retrograde passage of stents through an epicardial collateral vessel. Catheter Cardiovasc Interv. 2008 Sep 01; 72(3):365-9. PMID: 18727118.
      View in: PubMed
    116. Ye Y, Lin Y, Perez-Polo JR, Uretsky BF, Ye Z, Tieu BC, Birnbaum Y. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. J Immunol. 2008 Sep 01; 181(5):3515-23. PMID: 18714024.
      View in: PubMed
    117. Uretsky BF. Advancing backward: a word of caution. Catheter Cardiovasc Interv. 2008 Sep 01; 72(3):379-80. PMID: 18729174.
      View in: PubMed
    118. Uretsky B. A new tool to treat the chronically occluded coronary artery? Catheter Cardiovasc Interv. 2008 Aug 01; 72(2):164-5. PMID: 18651637.
      View in: PubMed
    119. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Card Fail. 2008 Oct; 14(8):670-5. PMID: 18926439.
      View in: PubMed
    120. Schwarz ER, Gupta R, Haager PK, vom Dahl J, Klues HG, Minartz J, Uretsky BF. Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up. Cardiology. 2009; 112(1):13-21. PMID: 18577881.
      View in: PubMed
    121. Uretsky BF. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008 Jun 12; 358(24):2639; author reply 2640-1. PMID: 18557170.
      View in: PubMed
    122. Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. Am J Physiol Heart Circ Physiol. 2008 Jul; 295(1):H343-51. PMID: 18469150.
      View in: PubMed
    123. Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv. 2008 Apr 01; 71(5):636-43. PMID: 18360856; PMCID: PMC4006950.
    124. Birnbaum Y, Lin Y, Ye Y, Merla R, Perez-Polo JR, Uretsky BF. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat. J Cardiovasc Pharmacol Ther. 2008 Mar; 13(1):72-9. PMID: 18287593.
      View in: PubMed
    125. Budoff MJ, Achenbach S, Berman DS, Fayad ZA, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task force 13: training in advanced cardiovascular imaging (computed tomography) endorsed by the American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2008 Jan 22; 51(3):409-14. PMID: 18206762.
      View in: PubMed
    126. Budoff MJ, Achenbach S, Berman DS, Fayad ZA, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task force 13: training in advanced cardiovascular imaging (computed tomography). J Cardiovasc Comput Tomogr. 2008 Mar-Apr; 2(2):130-5. PMID: 19083936.
      View in: PubMed
    127. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation. 2007 Nov 27; 116(22):2634-53. PMID: 17951284.
      View in: PubMed
    128. Manickavasagam S, Ye Y, Lin Y, Perez-Polo RJ, Huang MH, Lui CY, Hughes MG, McAdoo DJ, Uretsky BF, Birnbaum Y. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther. 2007 Oct; 21(5):321-30. PMID: 17620005.
      View in: PubMed
    129. Garg R, Uretsky BF, Lev EI. Anti-platelet and anti-thrombotic approaches in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2007 Sep; 70(3):388-406. PMID: 17722043.
      View in: PubMed
    130. Merla R, Daher IN, Ye Y, Uretsky BF, Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J. 2007 Aug; 154(2):391-402. PMID: 17643594.
      View in: PubMed
    131. Merla R, Ye Y, Lin Y, Manickavasagam S, Huang MH, Perez-Polo RJ, Uretsky BF, Birnbaum Y. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007 Sep; 293(3):H1918-28. PMID: 17616749.
      View in: PubMed
    132. Barbagelata A, Perna ER, Clemmensen P, Uretsky BF, Canella JP, Califf RM, Granger CB, Adams GL, Merla R, Birnbaum Y. Time to reperfusion in acute myocardial infarction. It is time to reduce it! J Electrocardiol. 2007 Jul; 40(3):257-64. PMID: 17478179.
      View in: PubMed
    133. Merla R, Reddy NK, Wang FW, Uretsky BF, Barbagelata A, Birnbaum Y. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis. Am J Cardiol. 2007 Sep 01; 100(5):770-6. PMID: 17719318.
      View in: PubMed
    134. Salinas G, Rangasetty UC, Uretsky BF, Birnbaum Y. The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J Cardiovasc Pharmacol Ther. 2007 Jun; 12(2):98-111. PMID: 17562780.
      View in: PubMed
    135. Ye Y, Nishi SP, Manickavasagam S, Lin Y, Huang MH, Perez-Polo JR, Uretsky BF, Birnbaum Y. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. Prostaglandins Other Lipid Mediat. 2007 Aug; 84(1-2):43-53. PMID: 17643887.
      View in: PubMed
    136. Ye Y, Lin Y, Perez-Polo R, Huang MH, Hughes MG, McAdoo DJ, Manickavasagam S, Uretsky BF, Birnbaum Y. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. Am J Physiol Heart Circ Physiol. 2007 Jul; 293(1):H813-8. PMID: 17416607.
      View in: PubMed
    137. Dehmer GJ, Babb JD, Uretsky BF, Seth A. SCAI: Going global. Catheter Cardiovasc Interv. 2007 Apr 01; 69(5):768-72. PMID: 17377974.
      View in: PubMed
    138. Huang MH, Wang HQ, Roeske WR, Birnbaum Y, Wu Y, Yang NP, Lin Y, Ye Y, McAdoo DJ, Hughes MG, Lick SD, Boor PJ, Lui CY, Uretsky BF. Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. Am J Physiol Heart Circ Physiol. 2007 Jul; 293(1):H376-84. PMID: 17369460.
      View in: PubMed
    139. Dehmer GJ, Blankenship J, Wharton TP, Seth A, Morrison DA, Dimario C, Muller D, Kellett M, Uretsky BF. The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2007 Mar 01; 69(4):471-8. PMID: 17278155.
      View in: PubMed
    140. Holmes DR, Uretsky BF. Interventional cardiology: the past, present, and the future. Indian Heart J. 2007 Mar-Apr; 59(2 Suppl B):B4-8. PMID: 19153435.
      View in: PubMed
    141. Birnbaum Y, Lin Y, Ye Y, Martinez JD, Huang MH, Lui CY, Perez-Polo JR, Uretsky BF. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. Am J Physiol Heart Circ Physiol. 2007 Jun; 292(6):H2891-7. PMID: 17277020.
      View in: PubMed
    142. Rosanio S, Schwarz ER, Vitarelli A, Zarraga IG, Kunapuli S, Ware DL, Birnbaum Y, Tuero E, Uretsky BF. Sudden death prophylaxis in heart failure. Int J Cardiol. 2007 Jul 31; 119(3):291-6. PMID: 17208319.
      View in: PubMed
    143. Schweiger MJ, Chambers CE, Davidson CJ, Zhang S, Blankenship J, Bhalla NP, Block PC, Dervan JP, Gasperetti C, Gerber L, Kleiman NS, Krone RJ, Phillips WJ, Siegel RM, Uretsky BF, Laskey WK. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007 Jan; 69(1):135-40. PMID: 17139671.
      View in: PubMed
    144. Salinas G, Kumar D, Lick S, Vijayakumar V, Rahman M, Uretsky BF. Infective coronary aneurysms: a complication of percutaneous coronary intervention. Tex Heart Inst J. 2007; 34(1):91-4. PMID: 17420801; PMCID: PMC1847918.
    145. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Huang MH, Perez-Polo JR, Uretsky BF. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat. 2007 Feb; 83(1-2):89-98. PMID: 17259075.
      View in: PubMed
    146. McGehee JT, Rangasetty UC, Atar S, Barbagelata NN, Uretsky BF, Birnbaum Y. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction. J Electrocardiol. 2007 Jan; 40(1):26-33. PMID: 17067628.
      View in: PubMed
    147. Uretsky BF, Wang FW. Implementation and application of a continuous quality improvement (CQI) program for the cardiac catheterization laboratory: one institution's 10-year experience. Catheter Cardiovasc Interv. 2006 Oct; 68(4):586-95. PMID: 16969834.
      View in: PubMed
    148. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Nishi SP, Martinez JD, Huang MH, Uretsky BF, Perez-Polo JR. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation. 2006 Aug 29; 114(9):929-35. PMID: 16908763.
      View in: PubMed
    149. Saeed M, Rahman A, Afzal A, Agoston I, Jammula P, Birnbaum Y, Ware DL, Uretsky BF, Schwarz ER, Rosanio S. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol. 2006 Nov 18; 113(3):401-5. PMID: 16822564.
      View in: PubMed
    150. Ahmad M, Jin Z, Xie T, Agoston I, Tiller F, Uretsky B. Live 3-d echocardiography in monitoring transcatheter closure of patent foramen ovale. Echocardiography. 2006 Jul; 23(6):525-7. PMID: 16839396.
      View in: PubMed
    151. Islam J, Uretsky BF, Sierpina VS. Heart failure improvement with CoQ10, Hawthorn, and magnesium in a patient scheduled for cardiac resynchronization-defibrillator therapy: a case study. Explore (NY). 2006 Jul-Aug; 2(4):339-41. PMID: 16846822.
      View in: PubMed
    152. Rangasetty UC, Gheorghiade M, Uretsky BF, Orlandi C, Barbagelata A. Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure. Expert Opin Investig Drugs. 2006 May; 15(5):533-40. PMID: 16634691.
      View in: PubMed
    153. Shilling K, Uretsky BF, Hunter GC. Entrapment of a cerebral embolic protection device--a case report. Vasc Endovascular Surg. 2006 May-Jun; 40(3):229-33. PMID: 16703211.
      View in: PubMed
    154. Atar S, Cannon CP, Murphy SA, Rosanio S, Uretsky BF, Birnbaum Y. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial. Am Heart J. 2006 May; 151(5):976.e1-6. PMID: 16644315.
      View in: PubMed
    155. Ye Y, Lin Y, Atar S, Huang MH, Perez-Polo JR, Uretsky BF, Birnbaum Y. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3):H1158-69. PMID: 16603698.
      View in: PubMed
    156. Budoff MJ, Achenbach S, Fayad Z, Berman DS, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task Force 12: training in advanced cardiovascular imaging (computed tomography): endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Atherosclerosis Imaging and Prevention, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2006 Feb 21; 47(4):915-20. PMID: 16487874.
      View in: PubMed
    157. Rosanio S, Ye Y, Atar S, Rahman AM, Freeberg SY, Huang MH, Uretsky BF, Birnbaum Y. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther. 2006 Feb; 20(1):27-36. PMID: 16435070.
      View in: PubMed
    158. Gupta R, Atar S, Schwarz ER, Uretsky BF, Birnbaum Y. Vineberg procedure for inadvertent injury to anomalous left anterior descending artery during tetralogy of fallot repair: four decades later. Tex Heart Inst J. 2006; 33(1):98-9. PMID: 16572885; PMCID: PMC1413612.
    159. Rangasetty UC, Raza S, Lick S, Uretsky BF, Birnbaum Y. Chronic pseudoaneurysm and coarctation of the aorta: a rare delayed complication of trauma. Tex Heart Inst J. 2006; 33(3):368-70. PMID: 17041699; PMCID: PMC1592259.
    160. Atar S, Ye Y, Lin Y, Freeberg SY, Nishi SP, Rosanio S, Huang MH, Uretsky BF, Perez-Polo JR, Birnbaum Y. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol. 2006 May; 290(5):H1960-8. PMID: 16339820.
      View in: PubMed
    161. Gupta R, Uretsky BF. Gadodiamide-based coronary angiography in a patient with severe renal insufficiency. J Interv Cardiol. 2005 Oct; 18(5):379-83. PMID: 16202115.
      View in: PubMed
    162. Rosanio S, Schwarz ER, Ahmad M, Jammula P, Vitarelli A, Uretsky BF, Birnbaum Y, Ware DL, Atar S, Saeed M. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol. 2005 Sep 01; 96(5):710-7. PMID: 16125501.
      View in: PubMed
    163. Uretsky BF. Society planning and consensus-building in 2005: where have we been? Where should we go next? Catheter Cardiovasc Interv. 2005 Sep; 66(1):52-4. PMID: 16106423.
      View in: PubMed
    164. Schwarz ER, Gupta R, Diep TP, Nowak B, Kostin S, Grohmann B, Uretsky BF, Schaper J. Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization. J Cardiovasc Pharmacol Ther. 2005 Sep; 10(3):181-90. PMID: 16211207.
      View in: PubMed
    165. Uretsky BF. The 2005 National Meeting at Ponte Vedra: a great meeting and a very good sign for the future. Catheter Cardiovasc Interv. 2005 Sep; 66(1):55-8. PMID: 16100715.
      View in: PubMed
    166. Uretsky BF. "The year of the Carotid": what I've learned (so far...). Catheter Cardiovasc Interv. 2005 Aug; 65(4):600-2. PMID: 16021639.
      View in: PubMed
    167. Uretsky BF. Small was good, will big be better? Catheter Cardiovasc Interv. 2005 Jun; 65(2):315-7. PMID: 15900558.
      View in: PubMed
    168. Gupta R, Rahman MA, Uretsky BF, Schwarz ER. Left main coronary artery thrombus: a case series with different outcomes. J Thromb Thrombolysis. 2005 Apr; 19(2):125-31. PMID: 16052304.
      View in: PubMed
    169. Jammula P, Gupta R, Uretsky BF. Images in cardiology: Anomalous origin of the right coronary artery from the left anterior descending artery. Heart. 2005 Apr; 91(4):e30. PMID: 15772179; PMCID: PMC1768792.
    170. Schuh A, Breuer S, Al Dashti R, Sulemanjee N, Hanrath P, Weber C, Uretsky BF, Schwarz ER. Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Ther. 2005 Mar; 10(1):55-66. PMID: 15821839.
      View in: PubMed
    171. Atar S, Uretsky BF, Birnbaum Y. Early post-thrombolysis catheterisation may be preferable to a conservative strategy for people with ST-elevation myocardial infarction. Commentary 1. Evid Based Cardiovasc Med. 2005 Mar; 9(1):55-8. PMID: 16379990.
      View in: PubMed
    172. Sanghi P, Uretsky BF, Schwarz ER. Vasopressin antagonism: a future treatment option in heart failure. Eur Heart J. 2005 Mar; 26(6):538-43. PMID: 15695526.
      View in: PubMed
    173. Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Hu ZY, Schwarz ER, Uretsky BF. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res. 2005 Feb 01; 65(2):345-55. PMID: 15639473.
      View in: PubMed
    174. Helmy TA, Nicholson WJ, Lick S, Uretsky BF. Contained myocardial rupture: a variant linking complete and incomplete rupture. Heart. 2005 Feb; 91(2):e13. PMID: 15657203; PMCID: PMC1768670.
    175. Schwarz ER, Meven DA, Sulemanjee NZ, Kersting PH, Tussing T, Skobel EC, Hanrath P, Uretsky BF. Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardium. J Cardiovasc Pharmacol Ther. 2004 Dec; 9(4):279-89. PMID: 15678247.
      View in: PubMed
    176. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004 Oct 06; 44(7):1343-53. PMID: 15464310.
      View in: PubMed
    177. Gedevanishvili A, Chamoun A, Uretsky BF, Rahman AM. Acute coronary syndrome induced by intravenous ephedrine in pregnant woman with normal coronaries. Can J Clin Pharmacol. 2004; 11(2):e195-8. PMID: 15520473.
      View in: PubMed
    178. Gupta R, Birnbaum Y, Uretsky BF. Calculation of creatinine clearance based on unadjusted body weight leads to errors in renal and heart failure patients. Circulation. 2004 Aug 17; 110(7):e70. PMID: 15313961.
      View in: PubMed
    179. Anzuini A, Chiesa R, Vivekananthan K, Uretsky B, Colombo A, Margonato A, Airoldi F, Rosanio S, Augello G, Birnbaum Y, Magnani G, Esposito G, Melissano G, Moura MR, Briguori C. Endovascular stenting for stenoses in surgically reconstructed brachiocephalic bypass grafts: immediate and midterm outcomes. J Endovasc Ther. 2004 Jun; 11(3):263-8. PMID: 15174907.
      View in: PubMed
    180. Osman A, Otero J, Brizolara A, Waxman S, Stouffer G, Fitzgerald P, Uretsky BF. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. Am Heart J. 2004 May; 147(5):e23. PMID: 15131558.
      View in: PubMed
    181. Tavackoli S, Ashitkov T, Hu ZY, Motamedi M, Uretsky BF, Birnbaum Y. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels. Coron Artery Dis. 2004 Feb; 15(1):53-8. PMID: 15201621.
      View in: PubMed
    182. Reffelmann T, Sensebat O, Birnbaum Y, Stroemer E, Hanrath P, Uretsky BF, Schwarz ER. A novel minimal-invasive model of chronic myocardial infarction in swine. Coron Artery Dis. 2004 Feb; 15(1):7-12. PMID: 15201615.
      View in: PubMed
    183. Anzuini A, Uretsky BF. Covered stent septal ablation for hypertrophic obstruction cardiomyopathy. Circulation. 2004 Jan 20; 109(2):e6. PMID: 14734509.
      View in: PubMed
    184. Birnbaum Y, Chamoun AJ, Anzuini A, Lick SD, Ahmad M, Uretsky BF. Ventricular free wall rupture following acute myocardial infarction. Coron Artery Dis. 2003 Sep; 14(6):463-70. PMID: 12966268.
      View in: PubMed
    185. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003 Jul 16; 290(3):353-9. PMID: 12865376.
      View in: PubMed
    186. Wang FW, Osman A, Otero J, Stouffer GA, Waxman S, Afzal A, Anzuini A, Uretsky BF. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation. 2003 Jun 17; 107(23):2914-9. PMID: 12771007.
      View in: PubMed
    187. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Rydén L. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003 Jan; 89(1):42-8. PMID: 12482789; PMCID: PMC1767481.
    188. Birnbaum Y, Ashitkov T, Uretsky BF, Ballinger S, Motamedi M. Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther. 2003 Jan; 17(1):25-30. PMID: 12843684.
      View in: PubMed
    189. Wiley JM, White CJ, Uretsky BF. Noncoronary complications of coronary intervention. Catheter Cardiovasc Interv. 2002 Oct; 57(2):257-65. PMID: 12357533.
      View in: PubMed
    190. Birnbaum Y, Chamoun AJ, Conti VR, Uretsky BF. Mitral regurgitation following acute myocardial infarction. Coron Artery Dis. 2002 Sep; 13(6):337-44. PMID: 12436029.
      View in: PubMed
    191. Mueller RN, Uretsky BF, Hao L, Walker DH, Panomitros GE, Zornow MH. Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogram. Anesthesiology. 2002 Sep; 97(3):745-9. PMID: 12218547.
      View in: PubMed
    192. Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol. 2002 Mar 20; 39(6):946-53. PMID: 11897434.
      View in: PubMed
    193. Wang F, Stouffer GA, Waxman S, Uretsky BF. Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era. Catheter Cardiovasc Interv. 2002 Feb; 55(2):142-7. PMID: 11835636.
      View in: PubMed
    194. Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Rydén L. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J. 2001 Sep; 22(17):1601-12. PMID: 11492990.
      View in: PubMed
    195. deFilippi CR, Rosanio S, Tocchi M, Parmar RJ, Potter MA, Uretsky BF, Runge MS. Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. J Am Coll Cardiol. 2001 Jun 15; 37(8):2042-9. PMID: 11419885.
      View in: PubMed
    196. Shah MR, Stinnett SS, McNulty SE, Gheorghiade M, Zannad F, Uretsky B, Adams KF, Califf RM, O'connor CM. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. Am Heart J. 2001 Jun; 141(6):908-14. PMID: 11376303.
      View in: PubMed
    197. Uretsky BF, Rosanio S, Lerakis S, Wang FW, Smiley M, Stouffer GA, Tocchi M, Estella P. A prospective evaluation of angiography-guided coronary stent implantation with high versus very high balloon inflation pressure. Am Heart J. 2000 Nov; 140(5):804-12. PMID: 11054629.
      View in: PubMed
    198. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000 Aug 08; 102(6):611-6. PMID: 10931799.
      View in: PubMed
    199. Lenihan DJ, Uretsky BF. Nonpharmacologic treatment of heart failure in the elderly. Clin Geriatr Med. 2000 Aug; 16(3):477-88. PMID: 10918643.
      View in: PubMed
    200. deFilippi CR, Tocchi M, Parmar RJ, Rosanio S, Abreo G, Potter MA, Runge MS, Uretsky BF. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol. 2000 Jun; 35(7):1827-34. PMID: 10841231.
      View in: PubMed
    201. Rosanio S, Tocchi M, Uretsky BF, Stouffer GA. Use of intraluminal stents in the treatment of carotid, renal, and peripheral arterial disease. Am J Med Sci. 2000 Feb; 319(2):111-7. PMID: 10698096.
      View in: PubMed
    202. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Rydén L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999 Dec 07; 100(23):2312-8. PMID: 10587334.
      View in: PubMed
    203. Rosanio S, Tocchi M, Cutler D, Uretsky BF, Stouffer GA, deFilippi CR, MacInerney EJ, Runge SR, Aaron J, Otero J, Garg S, Runge MS. Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry. JAMA. 1999 Jul 14; 282(2):145-52. PMID: 10411195.
      View in: PubMed
    204. O'Connor CM, Gattis WA, Uretsky BF, Adams KF, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1999 Jul; 138(1 Pt 1):78-86. PMID: 10385768.
      View in: PubMed
    205. Uretsky BF, Runge MS. Unstable angina. Introduction. Cardiol Clin. 1999 May; 17(2):xiii-xvii. PMID: 10384823.
      View in: PubMed
    206. Adams KF, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation. 1999 Apr 13; 99(14):1816-21. PMID: 10199877.
      View in: PubMed
    207. Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol. 1998 Sep; 32(3):686-92. PMID: 9741512.
      View in: PubMed
    208. Uretsky BF, Pina I, Quigg RJ, Brill JV, MacInerney EJ, Mintzer R, Armstrong PW. Beyond drug therapy: nonpharmacologic care of the patient with advanced heart failure. Am Heart J. 1998 Jun; 135(6 Pt 2 Su):S264-84. PMID: 9630090.
      View in: PubMed
    209. Lo MW, Toh J, Emmert SE, Ritter MA, Furtek CI, Lu H, Colucci WS, Uretsky BF, Rucinska E. Pharmacokinetics of intravenous and oral losartan in patients with heart failure. J Clin Pharmacol. 1998 Jun; 38(6):525-32. PMID: 9650542.
      View in: PubMed
    210. Runge MS, Stouffer GA, Sheahan RG, Uretsky BF. Perspectives on coronary stenting. Am J Med Sci. 1998 May; 315(5):322-6. PMID: 9587091.
      View in: PubMed
    211. Adams KF, Gheorghiade M, Uretsky BF, Young JB, Patterson JH, Tomasko L, Packer M. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy. Am Heart J. 1998 Mar; 135(3):389-97. PMID: 9506323.
      View in: PubMed
    212. Stouffer GA, Uretsky BF. Hemodynamic changes of aortic regurgitation. Am J Med Sci. 1997 Dec; 314(6):411-4. PMID: 9413349.
      View in: PubMed
    213. Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol. 1997 Dec; 30(7):1589-97. PMID: 9385881.
      View in: PubMed
    214. Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Wheeler W, Soler-Soler J, Swedberg K. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997 Jul; 134(1):44-54. PMID: 9266782.
      View in: PubMed
    215. Adams KF, Gheorghiade M, Uretsky BF, Young JB, Ahmed S, Tomasko L, Packer M. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997 Jul; 30(1):42-8. PMID: 9207619.
      View in: PubMed
    216. Lerakis S, Cutler D, Zhao D, Conti VR, Uretsky BF. Relation of unstable angina and myocardial infarction to progression of coronary narrowing in patients undergoing coronary artery bypass grafting (utilizing an internal mammary artery). Am J Cardiol. 1997 Jun 15; 79(12):1683-5. PMID: 9202365.
      View in: PubMed
    217. Uretsky BF. Implantable defibrillators in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 1997 Jun 05; 336(23):1677. PMID: 9173277.
      View in: PubMed
    218. Parmar RJ, Uretsky BF. Obliteration of a coronary artery aneurysm with percutaneous transluminal coronary angioplasty and stent placement. Cathet Cardiovasc Diagn. 1997 May; 41(1):51-2. PMID: 9143767.
      View in: PubMed
    219. Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jöbsis MM, Blackburn SD, Crow JW, Long WA. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation. 1997 Mar 18; 95(6):1479-86. PMID: 9118516.
      View in: PubMed
    220. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation. 1996 Dec 01; 94(11):2800-6. PMID: 8941105.
      View in: PubMed
    221. Mateo R, Jethmalani S, Angus DC, Gorcsan J, Uretsky B, Fung J. Interferon-associated left ventricular dysfunction in a liver transplant recipient. Dig Dis Sci. 1996 Jul; 41(7):1500-3. PMID: 8689931.
      View in: PubMed
    222. Lavee J, Kormos RL, Uretsky BF, Murali S, Donato W, Hardesty RL, Griffith BP. Prediction of mortality in patients awaiting cardiac transplantation: increased risk of sudden death in ischemic compared to idiopathic dilated cardiomyopathy. Isr J Med Sci. 1996 May; 32(5):282-7. PMID: 8641864.
      View in: PubMed
    223. MacGowan GA, Murali S, Loftus S, Uretsky BF. Comparison of metabolic, ventilatory, and neurohumoral responses during light forearm isometric exercise and isotonic exercise in congestive heart failure. Am J Cardiol. 1996 Feb 15; 77(5):391-6. PMID: 8602569.
      View in: PubMed
    224. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jöbsis MM, Blackburn SD, Shortino D, Crow JW. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996 Feb 01; 334(5):296-301. PMID: 8532025.
      View in: PubMed
    225. Lazar JM, Uretsky BF. Coronary artery fistula after heart transplantation: a disappearing entity? Cathet Cardiovasc Diagn. 1996 Jan; 37(1):10-3. PMID: 8770473.
      View in: PubMed
    226. Uretsky BF. Digoxin in the treatment of patients with chronic heart failure. Its place in therapy. Drugs Aging. 1995 Jul; 7(1):1-9. PMID: 7579776.
      View in: PubMed
    227. Ward RE, Gheorghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol. 1995 Jul; 26(1):93-101. PMID: 7797781.
      View in: PubMed
    228. Estrada-Quintero T, Uretsky BF, Murali S, Griffith BP, Kormos RL. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. Chest. 1995 Jun; 107(6):1499-503. PMID: 7781336.
      View in: PubMed
    229. Lazar JM, Uretsky BF, Denys BG, Reddy PS, Counihan PJ, Ragosta M. Predisposing risk factors and natural history of acute neurologic complications of left-sided cardiac catheterization. Am J Cardiol. 1995 May 15; 75(15):1056-60. PMID: 7747689.
      View in: PubMed
    230. Sueta CA, Gheorghiade M, Adams KF, Bourge RC, Murali S, Uretsky BF, Pritzker MR, McGoon MD, Butman SM, Grossman SH, et al. Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group. Am J Cardiol. 1995 Jan 19; 75(3):34A-43A. PMID: 7840053.
      View in: PubMed
    231. Rosenbaum AM, Murali S, Uretsky BF. Intra-aortic balloon counterpulsation as a 'bridge' to cardiac transplantation. Effects in nonischemic and ischemic cardiomyopathy. Chest. 1994 Dec; 106(6):1683-8. PMID: 7988184.
      View in: PubMed
    232. Carell ES, Murali S, Schulman DS, Estrada-Quintero T, Uretsky BF. Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest. 1994 Dec; 106(6):1746-52. PMID: 7988194.
      View in: PubMed
    233. Uretsky BF, Denys BG, Counihan PC, Ragosta M. Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. Cathet Cardiovasc Diagn. 1994 Dec; 33(4):323-9. PMID: 7889550.
      View in: PubMed
    234. Rubin DA, Uretsky BF, Zerbe TR, Estrada-Quintero T, Murali S. Increased plasma atrial natriuretic peptide levels after heart transplant: relation to ventricular expression and severity of rejection. Am Heart J. 1994 Oct; 128(4):769-73. PMID: 7942447.
      View in: PubMed
    235. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Denys BG, Armitage JM, Hardesty RL, Griffith BP. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993 Oct; 126(4):896-904. PMID: 8213447.
      View in: PubMed
    236. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct; 22(4):955-62. PMID: 8409069.
      View in: PubMed
    237. Young JB, Winters WL, Bourge R, Uretsky BF. 24th Bethesda conference: Cardiac transplantation. Task Force 4: Function of the heart transplant recipient. J Am Coll Cardiol. 1993 Jul; 22(1):31-41. PMID: 8509556.
      View in: PubMed
    238. Denys BG, Uretsky BF, Reddy PS. Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation. 1993 May; 87(5):1557-62. PMID: 8491011.
      View in: PubMed
    239. Rifkin RD, Uretsky BF. Screening for latent coronary artery disease by fluoroscopic detection of calcium in the coronary arteries. Am J Cardiol. 1993 Feb 15; 71(5):434-6. PMID: 8430633.
      View in: PubMed
    240. Schulman DS, Herman BA, Edwards TD, Ziady G, Uretsky BF. Diastolic dysfunction in cardiac transplant recipients: an important role in the response to increased afterload. Am Heart J. 1993 Feb; 125(2 Pt 1):435-42. PMID: 8427138.
      View in: PubMed
    241. O'Connell JB, Bourge RC, Costanzo-Nordin MR, Driscoll DJ, Morgan JP, Rose EA, Uretsky BF. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1992 Sep; 86(3):1061-79. PMID: 1516181.
      View in: PubMed
    242. Murali S, Uretsky BF, Armitage JM, Tokarczyk TR, Betschart AR, Kormos RL, Stein KL, Reddy PS, Hardesty RL, Griffith BP. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant. 1992 Jul-Aug; 11(4 Pt 1):716-23. PMID: 1498137.
      View in: PubMed
    243. Sandhu JS, Uretsky BF, Reddy PS, Denys BG, Ruffner RJ, Breisblatt WM, Zerbe TR, Kormos RL, Armitage JM, Hardesty RL, et al. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol. 1992 May 01; 69(14):1234-7. PMID: 1575196.
      View in: PubMed
    244. Uretsky BF, Kormos RL, Zerbe TR, Lee A, Tokarczyk TR, Murali S, Reddy PS, Denys BG, Griffith BP, Hardesty RL, et al. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S45-51. PMID: 1622998.
      View in: PubMed
    245. Zerbe T, Uretsky B, Kormos R, Armitage J, Wolyn T, Griffith B, Hardesty R, Duquesnoy R. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S104-10. PMID: 1622988.
      View in: PubMed
    246. Estrada-Quintero T, Uretsky BF, Murali S, Hardesty RL. Prolonged intraaortic balloon support for septal rupture after myocardial infarction. Ann Thorac Surg. 1992 Feb; 53(2):335-7. PMID: 1731681.
      View in: PubMed
    247. Uretsky BF. Sensory reinnervation of the heart after cardiac transplantation. N Engl J Med. 1992 Jan 02; 326(1):66-7; author reply 67-8. PMID: 1550604.
      View in: PubMed
    248. Murali S, Uretsky BF, Reddy PS, Tokarczyk TR, Betschart AR. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J. 1991 Nov; 122(5):1375-81. PMID: 1951003.
      View in: PubMed
    249. Hosenpud JD, DeMarco T, Frazier OH, Griffith BP, Uretsky BF, Menkis AH, O'Connell JB, Olivari MT, Valantine HA. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation. 1991 Nov; 84(5 Suppl):III338-43. PMID: 1934428.
      View in: PubMed
    250. Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS. Same-day angioplasty and diagnostic catheterization: safe and effective but riskier in unstable angina. Angiology. 1991 Aug; 42(8):607-13. PMID: 1892238.
      View in: PubMed
    251. Uretsky BF, Hua J. Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure. Am Heart J. 1991 Jun; 121(6 Pt 1):1879-86. PMID: 1674636.
      View in: PubMed
    252. Schulman DS, Herman BA, Ziady G, Edwards T, Kormos R, Reddy PS, Follansbee WP, Uretsky BF. Effects of acute alterations in left ventricular loading conditions on peak filling rate in the denervated (transplanted) ventricle. Am J Cardiol. 1991 May 15; 67(13):1103-9. PMID: 1902617.
      View in: PubMed
    253. Kaufman C, Zeevi A, Zerbe T, Keenan R, Kormos R, Griffith B, Hardesty R, Armitage J, Uretsky B, Duquesnoy RJ. In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease. Transplant Proc. 1991 Feb; 23(1 Pt 2):1142-3. PMID: 1989172.
      View in: PubMed
    254. Kormos RL, Armitage JM, Hardesty RL, Hattler BG, del Nido P, Marrone GC, Lee A, Uretsky BF, Murali S, Griffith BP. Cardiac transplantation at the University of Pittsburgh: 1980 to 1991. Clin Transpl. 1991; 87-95. PMID: 1820149.
      View in: PubMed
    255. Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic changes in cardiac tamponade. Am J Cardiol. 1990 Dec 15; 66(20):1487-91. PMID: 2251997.
      View in: PubMed
    256. Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benotti J, Murali S, Herrmann HC, Sandberg JA. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation. 1990 Sep; 82(3):774-80. PMID: 2144216.
      View in: PubMed
    257. Uretsky BF, Verbalis JG, Murali S, Betschart AR, Kolesar JA, Reddy PS. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J Clin Endocrinol Metab. 1990 Jul; 71(1):146-51. PMID: 2142492.
      View in: PubMed
    258. Hosenpud JD, Uretsky BF, Griffith BP, O'Connell JB, Olivari MT, Valantine HA. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. J Heart Transplant. 1990 Jul-Aug; 9(4):346-50. PMID: 2398427.
      View in: PubMed
    259. Kaufman CL, Zeevi A, Kormos RL, Zerbe TR, Keenan RJ, Uretsky BF, Griffith BP, Hardesty RL, Duquesnoy RJ. Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Hum Immunol. 1990 Jun; 28(2):228-36. PMID: 2351570.
      View in: PubMed
    260. Murali S, Uretsky BF, Betschart AR, Tokarczyk TR, Kolesar JA, Reddy PS. Differential hemodynamic effects of oral enoximone in severe congestive heart failure. Am J Cardiol. 1990 Feb 15; 65(7):515-9. PMID: 2137668.
      View in: PubMed
    261. Pahl E, Fricker FJ, Armitage J, Griffith BP, Taylor S, Uretsky BF, Beerman LB, Zuberbuhler JR. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 1990 Feb; 116(2):177-83. PMID: 2299487.
      View in: PubMed
    262. Villanueva FS, Murali S, Uretsky BF, Reddy PS, Griffith BP, Hardesty RL, Kormos RL. Resolution of severe pulmonary hypertension after heterotopic cardiac transplantation. J Am Coll Cardiol. 1989 Nov 01; 14(5):1239-43. PMID: 2808977.
      View in: PubMed
    263. Denys BG, Reddy PS, Uretsky BF. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency. Am J Cardiol. 1989 Aug 01; 64(5):405-6. PMID: 2667306.
      View in: PubMed
    264. Murali S, Uretsky BF, Reddy PS, Griffith BP, Hardesty RL, Trento A. Hemodynamic abnormalities following cardiac transplantation: relationship to hypertension and survival. Am Heart J. 1989 Aug; 118(2):334-41. PMID: 2665462.
      View in: PubMed
    265. Stone CK, Uretsky BF, Linnemeier TJ, Shah PK, Amin DK, Snapinn SM, Rush JE, Langendörfer A, Liang CS. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure. Am J Cardiol. 1989 Mar 01; 63(9):567-70. PMID: 2537566.
      View in: PubMed
    266. Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemaier T. Lisinopril for severe congestive heart failure. Am J Cardiol. 1989 Feb 21; 63(8):8D-11D. PMID: 2537565.
      View in: PubMed
    267. Sandhu JS, Uretsky BF, Zerbe TR, Goldsmith AS, Reddy PS, Kormos RL, Griffith BP, Hardesty RL. Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsy. Circulation. 1989 Feb; 79(2):350-6. PMID: 2644055.
      View in: PubMed
    268. McKoy RC, Uretsky BF, Kormos R, Hardesty RL, Griffith BP, Salerni R. Left ventricular hypertrophy in cyclosporine-induced systemic hypertension after cardiac transplantation. Am J Cardiol. 1988 Nov 15; 62(16):1140-2. PMID: 2973223.
      View in: PubMed
    269. Murali S, Uretsky BF, Kolesar JA, Valdes AM, Reddy PS. The acute effect of an oral "inotropic" placebo on the exercise capacity of patients with chronic cardiac failure. Chest. 1988 Aug; 94(2):262-6. PMID: 3396401.
      View in: PubMed
    270. Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemeier T, Rush JE, et al. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses. Am Heart J. 1988 Aug; 116(2 Pt 1):480-8. PMID: 2840815.
      View in: PubMed
    271. Uretsky BF, Rifkin RD, Sharma SC, Reddy PS. Value of fluoroscopy in the detection of coronary stenosis: influence of age, sex, and number of vessels calcified on diagnostic efficacy. Am Heart J. 1988 Feb; 115(2):323-33. PMID: 3341167.
      View in: PubMed
    272. Curtiss EI, Reddy PS, Uretsky BF, Cecchetti AA. Pulsus paradoxus: definition and relation to the severity of cardiac tamponade. Am Heart J. 1988 Feb; 115(2):391-8. PMID: 3341174.
      View in: PubMed
    273. Uretsky BF. Diagnostic considerations in the adult patient with cardiomyopathy or congestive heart failure. Cardiovasc Clin. 1988; 19(1):35-56. PMID: 3048686.
      View in: PubMed
    274. Uretsky BF, Lawless CE, Verbalis JG, Valdes AM, Kolesar JA, Reddy PS. Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy. Chest. 1987 Oct; 92(4):657-62. PMID: 3308346.
      View in: PubMed
    275. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987 Oct; 76(4):827-34. PMID: 3308166.
      View in: PubMed
    276. Murali S, Uretsky BF, Valdes AM, Kolesar JA, Reddy PS. Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure. Am J Cardiol. 1987 Jun 01; 59(15):1356-60. PMID: 3591691.
      View in: PubMed
    277. Curtiss EI, Fogoros RN, Uretsky BF, Follansbee WP, Salerni R. Electrocardiographically discrete right and left ventricular QRS complexes: a case report. J Electrocardiol. 1987 Apr; 20(2):162-8. PMID: 3598457.
      View in: PubMed
    278. Rahko PS, Salerni R, Uretsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol. 1986 Aug; 8(2):436-40. PMID: 3734266.
      View in: PubMed
    279. Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure. Am J Cardiol. 1986 Jul 01; 58(1):110-6. PMID: 2942027.
      View in: PubMed
    280. Unverferth DV, O'Dorisio TM, Miller MM, Uretsky BF, Magorien RD, Leier CV, Thompson ME, Hamlin RL. Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. J Lab Clin Med. 1986 Jul; 108(1):11-6. PMID: 3711722.
      View in: PubMed
    281. Uretsky BF. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering? Postgrad Med J. 1986 Jun; 62(728):585-92. PMID: 2946034; PMCID: PMC2418812.
    282. Rahko PS, Shaver JA, Salerni R, Uretsky BF. Noninvasive evaluation of systolic and diastolic function in severe congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1986 Jun 01; 57(15):1315-22. PMID: 3717032.
      View in: PubMed
    283. Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BF, Thompson ME, Leier CV. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986 Apr 01; 57(10):816-20. PMID: 2938462.
      View in: PubMed
    284. Uretsky BF, Valdes AM, Reddy PS. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Circulation. 1986 Mar; 73(3 Pt 2):III219-29. PMID: 2935328.
      View in: PubMed
    285. Uretsky BF, Seecof RM, Reddy PS. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response. Can J Cardiol. 1986 Mar-Apr; 2(2):80-5. PMID: 3085906.
      View in: PubMed
    286. Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. J Am Coll Cardiol. 1985 Jun; 5(6):1414-21. PMID: 3158689.
      View in: PubMed
    287. Greenberg ML, Uretsky BF, Reddy PS, Bernstein RL, Griffith BP, Hardesty RL, Thompson ME, Bahnson HT. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation. 1985 Mar; 71(3):487-94. PMID: 3882266.
      View in: PubMed
    288. Uretsky BF, Verbalis JG, Generalovich T, Valdes A, Reddy PS. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Am J Physiol. 1985 Mar; 248(3 Pt 2):H396-402. PMID: 3156513.
      View in: PubMed
    289. Uretsky BF. Idiopathic "myocarditis"? J Am Coll Cardiol. 1984 Nov; 4(5):1069. PMID: 6491078.
      View in: PubMed
    290. Uretsky BF, Generalovich T, Reddy PS, Salerni R, Valdes AM, Spangenberg RB, Lang JF, Okerholm RA. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. Am J Cardiol. 1984 Aug 01; 54(3):357-62. PMID: 6235735.
      View in: PubMed
    291. Itzkoff JM, Curtiss EI, Reddy PS, Uretsky BF, Shaver JA. Intermittent mitral regurgitation due to Beall valve dysfunction: analysis of 13 patients with atrial fibrillation. Am J Cardiol. 1984 Apr 01; 53(8):1071-4. PMID: 6702685.
      View in: PubMed
    292. Follansbee WP, Curtiss EI, Medsger TA, Steen VD, Uretsky BF, Owens GR, Rodnan GP. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med. 1984 Jan 19; 310(3):142-8. PMID: 6690931.
      View in: PubMed
    293. Reddy PS, Uretsky BF, Steinfeld M. The hemodynamic effects of intravenous verapamil in patients on chronic propranolol therapy. Am Heart J. 1984 Jan; 107(1):97-101. PMID: 6691247.
      View in: PubMed
    294. Uretsky BF, Generalovich T, Reddy PS, Spangenberg RB, Follansbee WP. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure. Circulation. 1983 Apr; 67(4):823-8. PMID: 6218939.
      View in: PubMed
    295. Uretsky BF. Left ventricular aneurysm by angiogram: a problem of definition. Am J Cardiol. 1983 Mar 01; 51(5):918. PMID: 6829460.
      View in: PubMed
    296. Uretsky BF. Does mitral valve prolapse cause nonspecific symptoms? Int J Cardiol. 1982; 1(5-6):435-42. PMID: 7118310.
      View in: PubMed
    297. Uretsky BF, Farquhar DS, Berezin AF, Hood WB. Symptomatic myocardial infarction without chest pain: prevalence and clinical course. Am J Cardiol. 1977 Oct; 40(4):498-503. PMID: 910714.
      View in: PubMed
    Uretsky's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _